Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Optinose Inc
(NQ:
OPTN
)
1.480
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Mar 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
443
Open
1.480
Bid (Size)
1.440 (2)
Ask (Size)
1.470 (1)
Prev. Close
1.480
Today's Range
1.480 - 1.480
52wk Range
0.9000 - 2.100
Shares Outstanding
53,309,012
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's After-Market Session
March 15, 2024
Via
Benzinga
XHANCE Approved by FDA as First and Only Medication Indicated for Treatment of Adults with Chronic Rhinosinusitis without Nasal Polyps
March 15, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Performance
YTD
+18.40%
+18.40%
1 Month
-10.30%
-10.30%
3 Month
+8.82%
+8.82%
6 Month
+18.40%
+18.40%
1 Year
-26.00%
-26.00%
More News
Read More
OPTN Stock Earnings: OptiNose Meets EPS, Beats Revenue for Q4 2023
March 07, 2024
Via
InvestorPlace
Optinose Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Operational Highlights
March 07, 2024
From
Optinose, Inc.
Via
GlobeNewswire
OptiNose's Earnings: A Preview
March 06, 2024
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Via
Benzinga
Optinose Announces Reporting Date for Fourth Quarter 2023 Financial Results
February 29, 2024
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces the Publication of ReOpen Phase 3 Clinical Trial Program Evaluating XHANCE in the Journal of Allergy and Clinical Immunology: In Practice
January 18, 2024
From
Optinose, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
December 06, 2023
Via
Benzinga
Gold Moves Higher; Campbell Soup Earnings Top Expectations
December 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 06, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
December 06, 2023
Via
Benzinga
Crude Oil Down 4%; Pharvaris Shares Spike Higher
December 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
US Stocks Higher; Private Payrolls Rise By 103,000 In November
December 06, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why ENT-Focused OptiNose Shares Are Diving Today
December 06, 2023
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 06, 2023
Via
Benzinga
Optinose Announces 3-Month Extension of FDA Review Period for the Supplemental New Drug Application for XHANCE
December 06, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 35th Annual Piper Sandler Healthcare Conference
November 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Reports Third Quarter 2023 Financial Results and Operational Updates
November 09, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose Announces Reporting Date for Third Quarter 2023 Financial Results
October 27, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Optinose to Present at the 2023 Cantor Global Healthcare Conference
September 22, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For August 21, 2023
August 21, 2023
Via
Benzinga
Optinose Reports Second Quarter 2023 Financial Results and Operational Updates
August 10, 2023
From
Optinose, Inc.
Via
GlobeNewswire
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
July 28, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.